Ranbaxy Laboratories Limited Stock

Stocks

End-of-day quote NSE India S.E. Other stock markets
- ^INR	-

07/03/16	UCB : Pharma crusader takes India's drug regulators to court	RE
29/06/15	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE

07/03/16	UCB : Pharma crusader takes India's drug regulators to court	RE
29/06/15	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE
20/04/15	DAIICHI SANKYO : Japan's Daiichi Sankyo to sell up to $3.6 billion Sun Pharma stake	RE
30/01/15	DAIICHI SANKYO : Sun Pharmaceutical wins U.S. approval to buy Ranbaxy	RE
06/12/14	AstraZeneca : Ranbaxy prevail in Nexium antitrust trial	RE
20/11/14	AstraZeneca : U.S. court denies Ranbaxy's bid to block launch of rival generics	RE
18/11/14	AstraZeneca : Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies	RE
28/10/14	GlaxoSmithKline : Novartis results top forecasts as new products gain momentum	RE
31/07/14	AbbVie : AstraZeneca raises forecasts after seeing off Pfizer	RE
25/07/14	AbbVie : AstraZeneca results to get lift from bid foe Pfizer	RE
17/07/14	Novartis : Drugmaker Novartis to eke out more cost savings to lift margins	RE
24/06/14	Abbott India : Exclusive - India likely to extend price caps to more drugs: sources	RE
19/06/14	Mylan : EU to fine Servier, Teva for delaying generic drugs - sources	RE

04/03/15	Ranbaxy Laboratories : & APICON BREAK GUINNESS WORLD RECORD™	PU
28/01/15	Ranbaxy Laboratories : Q3FY 2015 Sales Rs.25,876Mn. YTD Dec’14 Sales Rs.81,778Mn	PU
06/12/14	Ranbaxy Laboratories : launches Red Heart Initiative to Raise Awareness on Women Heart Health	PU
01/12/14	Ranbaxy Laboratories : launches India’s first biosimilar of Infliximab drug, Infimab™	PU
29/07/14	Ranbaxy Laboratories : Q1 FY 2015 (Apr’14-Jun’14) Sales Rs.23.7 Bn	PU

17/07/14	Novartis : confirme l'objectif de croissance de ses ventes
17/07/14	Novartis : confirme l'objectif de croissance du C.A. annuel
19/06/14	Servier, Teva, d'autres à l'amende pour du "pay-for-delay"-sces
22/04/14	S& 500 : Vague de fusions dans le domaine de la pharmacie
07/04/14	Sun Pharmaceutical : Inde/Génériques-Sun Pharma acquiert Ranbaxy pour $3,2 mds

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+1.66%	+2.76%	+59.01%	+161.37%	1,043B
JOHNSON & JOHNSON	-0.12%	+0.49%	+50.70%	+48.52%	621B
ABBVIE INC.	-0.75%	-5.31%	+24.16%	+62.13%	435B
ROCHE HOLDING AG	0.00%	+3.20%	+46.70%	+37.70%	361B
NOVARTIS AG	+0.58%	-1.26%	+35.52%	+39.32%	293B
ASTRAZENECA PLC	-1.55%	-6.84%	+7.20%	+8.86%	251B
AMGEN INC.	-1.04%	+3.94%	+41.53%	+59.29%	220B
NOVO NORDISK A/S	-0.24%	-11.27%	+1.42%	-46.20%	201B
GILEAD SCIENCES, INC.	-1.34%	-1.10%	+17.73%	+60.94%	164B
Average	-0.26%	-3.81%	+31.55%	+47.99%	398.79B
Weighted average by Cap.	+0.22%	-3.79%	+40.39%	+74.27%